Matthew S Callander, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1414 W Fair Ave, Suite 36, Marquette, MI 49855 Phone: 906-225-3864 Fax: 906-225-3851 |
News Archive
Therics, Inc., a subsidiary of Tredegar Corporation, announced that it has received FDA clearance to market a new resorbable beta-tricalcium phosphate bone void filler device used to treat osseous defects of the skeletal system.
A new book providing practical suggestions on how parents and professionals can help children with Down Syndrome (DS) develop lifelong motor skills will be published later this month.
Type 2 diabetes is driven by many metabolic pathways, with some pathways driven by amino acids, the molecular building blocks for proteins.
Ten years after the identification of the first breast cancer susceptibility genes so few high-risk minority women have received genetic counseling or testing that the standard methods of calculating risk have not been validated in these groups and the results of genetic testing can still produce surprises.
The preliminary trial results of a novel radiopharmaceutical for PET imaging of inflammation developed at the University of Turku, Finland, have been published.
› Verified 3 days ago